Cell Source Inc (CLCS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CLCS Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Cell Source Inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2025)
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Prepaid Expense, Current AS0.08
Total Current Assets0.08
Other Assets, Noncurrent0.21
Subscription Receivable-
Total Assets0.29
Liabilities
Accounts Payable, Current AC1.93
Accrued Liabilities, Current1.44
Derivative Liability, Current DE0.54
Short-term Debt1.37
Deferred Compensation Liability, Current LI1.09
Total Current Liabilities6.38
Total Long-term Debt0.00
Other liabilities, Noncurrent14.05
Warrant Liabilities Current0.09
Total Liabilities20.43
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock27.48
Retained Earnings / Accumulated Deficit-47.66
Other Equity0.00
Common Stockholder's Equity-20.14
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-20.14
Liabilities & Stockholder's Equity0.29
4 historic quarters locked

Sign in to unlock the full Cell Source Inc balance sheet history.

About Cell Source Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20250331)
  • Filed with the SEC: May 14, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-022926

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.